High Point, NC – According to filings with the U.S. Securities and Exchange Commission, vTv Therapeutics is raising $10,000,000.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Rudy Howard played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About vTv Therapeutics

vTv Therapeutics LLC (vTv) is a clinical-stage pharmaceutical company focused on treating metabolic diseases to minimize their long-term complications through end-organ protection. Our mission is to advance clinical drug candidates discovered with our innovative technology into safe and effective medicines. vTv has an innovative pipeline of first-in-class small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of metabolic diseases and their long term complications such as type 1 diabetes and Alzheimer’s disease. The company has built its product candidate portfolio through internal discovery and is advancing its product candidates through in-house research and development efforts.

To learn more about vTv Therapeutics, visit http://www.vtvtherapeutics.com/

Contact:
Rudy Howard, Chief Financial Officer
336-841-0300
rhoward@vtvtherapeutics.com
https://www.linkedin.com/in/rudy-howard-2482448/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved